Outcomes of Vedolizumab Treatment in Patients With Immune Checkpoint Inhibitor-Induced Diarrhea and Colitis: A Multi-Center Study
Abu-Sbeih H, Ali F, Alsaadi D, Jennings J, Luo W, Gong Z, Richards D, Charabaty A, Wang Y. Outcomes of Vedolizumab Treatment in Patients With Immune Checkpoint Inhibitor-Induced Diarrhea and Colitis: A Multi-Center Study. The American Journal Of Gastroenterology 2018, 113: s58. DOI: 10.14309/00000434-201810001-00110.Peer-Reviewed Original ResearchThe Constellation of Upper Gastrointestinal Symptoms and Associated Endoscopic and Histologic Features in Patients Receiving Immune Checkpoint Inhibitors
Tang T, Abu-Sbeih H, Luo W, Samdani R, Qiao W, Bresalier R, Richards D, Wang Y. The Constellation of Upper Gastrointestinal Symptoms and Associated Endoscopic and Histologic Features in Patients Receiving Immune Checkpoint Inhibitors. The American Journal Of Gastroenterology 2018, 113: s705. DOI: 10.14309/00000434-201810001-01231.Peer-Reviewed Original Research